OTONOMY
Otonomy is an expert in the otology field in order to build the premier company dedicated to the treatment of otic disorders via localized drug delivery. This approach has already been widely adopted for the delivery of short-acting antibiotics to treat otitis media through a tympanostomy tube. In addition, otolaryngologists have demonstrated that the injection of steroids into the middle ear cavity can provide a therapeutic effect for patients with acute inner ear disorders such as Ménière’... s disease and sudden sensorineural hearing loss. Expansion of this effort holds great promise for the treatment of chronic hearing loss, severe vertigo, and even tinnitus. The key to Otonomy's leading position in this nascent field is the development of a proprietary formulation platform that provides sustained drug exposure from a single administration. Broad application of this technology has already been established across a number of therapeutic classes, and from these, three product candidates have been advanced into development.
OTONOMY
Industry:
Biopharma Biotechnology Health Care
Founded:
2008-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.otonomy.com
Total Employee:
51+
Status:
Active
Contact:
+1 8587687809
Email Addresses:
[email protected]
Total Funding:
458.01 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome Domain Not Resolving Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Epizyme
Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.
QRxPharma
QRxPharma is a pharmaceutical company that develops and commercializes pain management and abuse prevention products.
Relypsa
Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.
Vaxcyte
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Tetraphase Pharmaceuticals
Tetraphase Pharmaceuticals is a company leveraging a dynamic drug engine targeted at several significant disease categories.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Perceptive Advisors
Perceptive Advisors investment in Series D - Otonomy
Avalon Ventures
Avalon Ventures investment in Series D - Otonomy
TPG Biotech
TPG Biotech investment in Series D - Otonomy
Domain Associates
Domain Associates investment in Series D - Otonomy
RiverVest
RiverVest investment in Series D - Otonomy
Novo Ventures
Novo Ventures investment in Series D - Otonomy
Jennison Associates
Jennison Associates investment in Series D - Otonomy
OrbiMed
OrbiMed investment in Series D - Otonomy
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series D - Otonomy
Federated Investors
Federated Investors investment in Series D - Otonomy
Official Site Inspections
http://www.otonomy.com Semrush global rank: 3.66 M Semrush visits lastest month: 3.85 K
- Host name: 107.139.231.35.bc.googleusercontent.com
- IP address: 35.231.139.107
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Otonomy"
Otonomy - Crunchbase Company Profile & Funding
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.See details»
Otonomy Inc - AnnualReports.com
Otonomy, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of diseases and disorders of the ear in the …See details»
Otonomi Company Profile 2024: Valuation, Funding & Investors
Otonomi General Information Description. Operator of a blockchain-enabled parametric platform intended to transform cargo insurance policies into fast, cost-effective and transparent digital …See details»
Why We Invested: OTONOMI — REFASHIOND Ventures
Nov 2, 2021 Moreover, the trend I highlighted in Commentary: Competition in e-commerce is heating up!, published by FreightWaves on August 6, 2019, about 2018 data from the World …See details»
Otonomy - Funding, Financials, Valuation & Investors - Crunchbase
Sep 4, 2020 Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.See details»
Otonomy, Inc - LinkedIn
Otonomy, Inc | 2,945 followers on LinkedIn. Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The …See details»
Otonomi - Funding, Financials, Valuation & Investors - Crunchbase
Otonomi is a parametric insurance platform that provides underwriting, claims automation, and digital funds management services. Search Crunchbase. ... How much funding has this …See details»
Otonomy - VentureRadar
"Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery …See details»
Otonomy Company Profile - Office Locations, Competitors ... - Craft
Jul 18, 2024 Otonomy has 5 employees at their 1 location and $125 k in annual revenue in FY 2021. See insights on Otonomy including office locations, competitors, revenue, financials, …See details»
What is Otonomy? - Otonomy
Otonomy is an online matchmaking platform for buyers and sellers of small businesses. It is a single place for current and future small business owners to connect, interact, research and …See details»
Yann Barbarroux - CEO, Otonomi | Loyalty Alliance
Jun 16, 2021 OTONOMI, a promising Brooklyn-based InsurTech Seed-Stage “Startups to Follow in 2021”, is a Parametric Insurance Platform. Their technology drives efficiencies in operations …See details»
OTONOMI — Team members interview series. Meet Yann …
May 19, 2021 Hey there, I am Yann Barbarroux. CEO and co-founder of OTONOMI, an insurtech focused on transforming the transportation and cargo insurance industry. I was born …See details»
Otonomy Reports Corporate and Product Pipeline Update
Jan 6, 2022 Multiple clinical trial readouts for OTO-313 in tinnitus and OTO-413 in hearing loss expected during 2022 Current capital funds operations into second...See details»
Why We Invested: OTONOMI - Innovation Footprints
Moreover, the trend I highlighted in Commentary: Competition in e-commerce is heating up!, published by FreightWaves on August 6, 2019, about 2018 data from the World Trade …See details»
OTONOMI Secures $11.5 million Reinsurance Capacity Through …
Dec 8, 2021 OTONOMI is thrilled to announce our official partnership with Bermuda-based decentralized reinsurer Ensuro, to back our parametric cargo insurance products and develop …See details»
Otonomy - Crunchbase Company Profile & Funding
Otonomy is an online matchmaking platform for buyers and sellers of small businesses.See details»
Otonomi Case Study | OAG
Otonomi launched in 2020 and has since raised $1.2M in seed funding and launched the first ever air cargo delay index on the Nasdaq Global Index. Find out below how Otonomi uses OAG …See details»
What Can I Do On Otonomy? - Otonomy
Otonomy is an online matchmaking platform for buyers and sellers of small businesses. It is a single place for current and future small business owners to connect, interact, research and …See details»
How Does Otonomy's Pricing Work? - Otonomy
Pricing Joining the Otonomy platform is completely free. There is no cost to create a profile, search for small businesses that are for sale or access online resources. The only cost with …See details»
Buy/Sell Small Businesses Faster In Canada on Otonomy.ca
Matchmaking Buyers and Sellers of Small Businesses in Canada. Otonomy enables current and future small business owners to connect, interact, research and ultimately match faster!See details»